Company Profile

DISHMAN CARBOGEN AMCIS LTD.

NSE : DCALBSE : 540701ISIN CODE : INE385W01011Industry : Pharmaceuticals & DrugsHouse : Dishman Pharma
BSE124.150.45 (+0.36 % )
PREV CLOSE (Rs.) 123.70
OPEN PRICE (Rs.) 122.60
BID PRICE (QTY) 124.15 (1000 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 5993
TODAY'S LOW / HIGH (Rs.)122.60 124.90
52 WK LOW / HIGH (Rs.)109.8 258.15
NSE124.40 0.8 (+0.65 % )
PREV CLOSE(Rs.) 123.60
OPEN PRICE (Rs.) 124.50
BID PRICE (QTY) 124.40 (265 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 90898
TODAY'S LOW / HIGH(Rs.) 122.65 125.00
52 WK LOW / HIGH (Rs.)109.7 257.35

Smart Quotes

1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Trade Value (Rs. in Lacs) 7.43739
Dividend Yield(%)
TTM EPS (Rs.)
P/E Ratio
Book Value (Rs.)
Face Value (Rs.)
MCap (Rs. in Mn)
Price/Earning (TTM)
Price/Sales (TTM)
Price/Book (MRQ)
PAT Margin (%) 10.19
ROCE (%) 2.37
Incorporation Year : 2007

Management Info :

Janmejay R Vyas - Chairman Arpit J Vyas - Managing Director

Registered Office :

Address : Dishman Corporate House,Lscon-bopal Road,Ambli,
Ahmedabad,
Gujarat-380058

Phone : 02717 420102

Registrar's Details : Link Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE
NEWS More
02Dec12-02-2019$Dishman Carbogen Amcis informs about change in registered office address Dishman Carbogen Amcis infor

In furtherance to letter regarding outcome of Board Meeting dated 23rd October, 2019, Dishman Carbogen Amcis has informed that address of Registered Office of the Company has been changed from Bhadra-Raj Chambers, Swastik Cross Roads, Navrangpura, Ahmedabad - 380009 to Dishman Carbogen Amcis, Dishman Corporate House, Iscon-Bopal Road, Ambli, Ahmedabad - 380058, Gujarat, India. Tel. No.: 02717-400102/124, with effect from 1st December, 2019.

The above information is a part of company’s filings submitted to BSE.

In furtherance to letter regarding outcome of Board Meeting dat..
24Oct10-24-2019$Change of Registered Office Change of Registered Office
inter alia, approved the following: 1) To shift registered office of the Company from its present location at "Bhadr-Raj Chambers, Swastik Cross Roads, Navrangpura, Ahmedabad - 380009, Gujarat" to "Dishman Corporate House, lscon-Bopal Road, Ambli, Ahmedabad - 380058, Gujarat" w.e.f. 1st December, 2019.
inter alia, approved the following: 1) To shift registered offi..
16Oct10-16-2019$ Board Meeting Intimation for REGULATION 29 Board Meeting Intimation fo
Dishman Carbogen Amcis Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/10/2019 ,inter alia, to consider and approve Pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the meeting of the Board of Directors of the Company will be held on Wednesday, the 23rd day of October, 2019, inter alia, to consider, take on record and approve the Un-Audited Financial Results of the Company for the quarter and half year ended on 30th September, 2019. In view of the same, we would like to inform you further to our intimation dated 30th September, 2019 that the Trading Window for dealing in the securities of the Company will open from 26th October, 2019. The Trading Window would remain closed from 1st October, 2019 to 25th October, 2019 (both days inclusive) for dealing in Securities of the Company by all the Directors, Designated Persons and their immediate relative(s).
Dishman Carbogen Amcis Ltdhas informed BSE that the meeting of..
03Oct10-03-2019$Hero MotoCorp, Infosys and M&M to see some action today Hero MotoCorp, Infosys and M

Hero MotoCorp has opened a world-class training centre - The Centre of Excellence - at the Industrial Training Institute, Nizamuddin in New Delhi. The launched in association with the Department of Training and Technical Education, Government of the National Capital Territory of Delhi, the centre will build key skillset amongst the youth, thereby enhancing career opportunities for them in the two-wheeler industry.

Infosys and SAP are in talks to create a joint go-to-market engagement model between project Embrace from SAP and Infosys' Innov8 program. The joint engagement model is intended to help companies accelerate their digital transformation based on SAP S/4HANA to build intelligent enterprises.

Mahindra & Mahindra (M&M) along with Ford Motor Company Inc., USA (FMC) have executed a Business Transfer Agreement and Share Subscription Agreement to enable the formation of a joint venture by way of the Company and/ or its subsidiaries acquiring 51% of the equity share capital of Ardour Automotive, a wholly owned subsidiary of FMC (NewCo') in India.

APL Apollo Tubes has registered a strong sales volume of 3,63,994 MTPA in Q2FY20, higher by 20% Y-o-Y from 3,04,058 MTPA in Q2FY19. The growth was led by strong demand in Apollo Structural and Apollo Z. Q2FY20 was Apollo Tricoat’s first quarter of full operations. The volumes from Apollo Tricoat stood strong at 27,529 MTPA, which further assisted overall volume growth during the quarter.

Dishman Carbogen Amcis has received approval to acquire the shares of Dishman Biotech as part of strategic investment for Rs 4.50 crore. Dishman Biotech is engaged in the business of manufacturing of Bulk Drugs and Drug formulations.

INDSIL Hydro Power and Manganese has terminated lease agreement with Nikita Metachem regarding the lease of part of specified Plant & Machinery at the company’s Raipur factory. The company has terminated lease agreement with effect from October 01, 2019.

Info Edge (India) has invested, through its wholly-owned subsidiary, about Rs 6 crore in Happily Unmarried Marketing. As part of company’s strategic investments, the investment would help the company to consolidate its position into the said line of business within the Internet Services industry.

Hero MotoCorp has opened a world-class training centre - The Ce..
01Oct10-01-2019$ Announcement under Regulation 30 (LODR)-Acquisition Announcement under Regulati
DISCLOSURE PURSUANT TO REGULATION 30 OF SEBI (LODR) REGULATIONS, 2015 - ACQUISITION OF SHARES OF DISHMAN BIOTECH LIMITED
DISCLOSURE PURSUANT TO REGULATION 30 OF SEBI (LODR) REGULATIONS..
Financials More
Rs. in Millions
QTR Sep 19 ANNUAL 19
Net Profit326.8560.1
Gross Profit 487.1 817.3
Operating Profit 944.62654.7
Net Sales 1777.55494.8
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group More
Astrazeneca Pharma I (BSE)
 2761.55 (4.11%)
M.Cap ( in Cr)
6903.88
Sanofi India (BSE)
 7018.65 (0.70%)
M.Cap ( in Cr)
16164.39
Divis Lab (BSE)
 1806.35 (1.30%)
M.Cap ( in Cr)
47952.92
Hester Biosciences (BSE)
 1574.70 (1.33%)
M.Cap ( in Cr)
1339.58
Torrent Pharma (BSE)
 1867.95 (0.94%)
M.Cap ( in Cr)
31607.34
Shareholding Pattern More
PROMOTERS 61.4 %
NON-INSTITUTION 17.39 %
MUTUAL FUNDS/UTI 12.12 %
FI/BANKS/INSURANCE 0.29 %
GOVERNMENT 0 %
FII 0 %
F & O Quotes